COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody?

Blood Adv. 2024 Oct 25:bloodadvances.2024013792. doi: 10.1182/bloodadvances.2024013792. Online ahead of print.

¹ Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.
² Hematology Unit, Department of Medicine, University of Padova, Padova, Italy.
³ ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milano, Italy.
⁴ Univeristy of Torino, Torino, Italy.
⁵ Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome, Idaho, Italy.
⁶ Hematology-Oncology and Stem-Cell Transplantation Unit, Department of Onco-Hematology and Innovative Diagnostics, Istituto Nazionale Tumori IRCCS - Fondazione "G. Pascale", Naples, Italy.
⁷ Hematology Unit - A.O.U.P. Ospedale Santa Chiara, Pisa, Italy.
⁸ AOU Careggi, Florence, Italy.
⁹ ASUFC, Udine, Italy.
¹⁰ Ospedali Riuniti Ancona.
¹¹ UOC Ematologia Tor Vergata, Rome, Italy.
¹² University of Perugia, Perugia, Italy.
¹³ Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy, roma, Italy.
¹⁴ University of Torino, Torino, Italy.
¹⁵ University of Padua, PADOVA, Italy.
¹⁶ Dept. of Medical and Surgical Sciences University of Modena and Reggio Emilia, MODENA, Italy.
¹⁷ A.O.U. Città della Salute e della Scienza, Turin, Italy.
¹⁸ Hematology, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy, Rome, Italy.
¹⁹ Fondazione Policlinico Universitario A Gemelli Roma IRCCS, roma, Italy.

No abstract available